The potential influence of metyrapone (M) induced hypocortisolemia on plasma pituitary hormones other than ACTH has been the subject of several studies. Particularly, the findings about influences on the somatotrophic system are rather controversial (Kunita, Takebe, Nakagawa, Sawano and Horiuchi 1970;Sawin, Spark and Mitchell 1971;Bruno, Leclerq, Virasor and Copinski 1971; Takahara, Ogawa and Ofuji 1972; Sawano, Saito, Shizume and Takebe 1972;Bacon, Larson, Spencer and Kelch 1975). Similarly contradictory, scanty or non-existent is the information about alterations of the gonadotrophic (Sakakura, Takebe and Nakagawa 1975;Muraleedharan, Sialy and Rastogi 1977; Sakakura, Yoshioka and Takebe 1978), the thyrotrophic (Re, Kourides, Ridgway, Weintraub and Maloof 1976), and lactotrophic function of the pituitary. We report here on the short-time kinetic profiles of plasma ACTH, STH, LH, FSH, prolactin and TSH after oral application of M. § 100 | 50 u < 10 a. I 5 3.5 3.0 -2.5 | 2.0 -1.5 £ i.o 0.5 J i M \H -^ •-. 1 . H \ NHH / Hh 9 1t 13 15 Fig. Mean (± SEM) plasma levels of pituitary hormones before and after oral administration of 40 mg of metyrapone/kg at 8.15 h
Protocol and MethodsFour healthy men volunteered for the study. 40 mg of M/kg were administered orally at 8.15 h. Blood for estimation of plasma hormones was taken before and at short intervals after administration of M. Plasma ACTH was estimated radioimmunologically after concentration by QUSO-extraction (.Schoneshdfer, Schefzig and Arabin 1980). Concentrations of the other pituitary hormones were estimated using commercial radioimmunoassay reagents adapted to the Centria-technique (Mèriadec, Jolu and Henry 1979). Standards equivalent to the following international preparations were used in the hormone assays: MRC 69/104 for FSH and LH, WHO 75/504 for prolactin and MRC 68/38 for TSH.
Results and DiscussionThe Figure shows the profiles of the mean plasma levels of pituitary hormones during the experiments. Distinct alterations were found for the plasma concentrations of ACTH, STH and prolactin. Whereas the cumulative profile of plasma ACTH is characterized by two peaking phases, the corresponding profiles of plasma STH and prolactin exhibit only one peaking phase, which is concomitant with the first peak of ACTH. Although individual responses differed strongly, the initial peak was significant for plasma ACTH and STH (p < 0.01) but not significant for plasma prolactin. In three subjects, plasma prolactin remained almost unaltered, whereas, in one subject suffering strongly from nausea during the phase of absorption of the drug, a tremendous initial rise of plasma prolactin as well as of plasma ACTH and STH was apparent.Changes of plasma Cortisol and 11-deoxycortisol documented in detail elsewhere (Schöneshöfer, Schefzig and Arabin 1980) reflected a complete blockade of adrenal 11-hydroxylase as early as two hours after drug administration. Plasma 11-deoxycortisol thereby exhibited a biphasic course similar to that of plasma ACTH. These data emphasize the hyp...